Business Post logo
  • SUBSCRIBE
  • Log
  • menu
  • menu
  • Brexit
  • Coronavirus
  • Companies
  • Data
  • US
  • SMEs
  • Health
  • Legal
  • Climate & Environment
  • Housing
  • Podcasts
  • Focus On
  • Crosswords
Close menu
  • News
  • Politics
  • News Focus
  • Analysis & Opinion
  • Tech
  • Life & Arts
  • Property
  • Food & Wine
  • Irish Tatler
  • Benefits

Luke O’Neill

Business

Amryt entrepreneur Cathal Friel aims to do an IPO every year

‘This is only the start,’ the Donegal businessman says of the four initial public offerings in which he has already had an involvement
  • Ellie Donnelly
  • January 14, 2023
Health

Open Orphan founder says Covid-19 ‘is over’

Cathal Friel, the head of the pharma firm, has contradicted official advice to isolate, and says the virus should now be treated like a cold or flu
  • Lorcan Allen
  • September 24, 2022
Companies

Oral vaccines for Covid-19 expected by 2030

Dublin and Cork-based firms are collaborating to bring infectious disease prevention to the ‘next level’
  • Lorcan Allen
  • May 22, 2022

Poolbeg Pharma lands deal with AI firm to pinpoint effective virus drugs

US giant OneThree Biotech will lend Open Orphan spinout its state-of-the-art technology to accelerate treatment of severe respiratory infection RSV
  • Lorcan Allen
  • February 27, 2022

Elaine Byrne: Why we need to be faster and clearer in dealing with a crisis

If we’ve learned anything from the trauma of the pandemic, it’s that maintaining public trust in health policies is critical
  • Elaine Byrne
  • December 26, 2021

Covid-19: Wonder drugs become another weapon in ongoing battle against the virus

Recent tests by Merck of an antiviral pill that appears to cut hospitalisation risk by 50 per cent sent the company’s shares soaring. Other companies, including Dublin-based AiPharma, are also in the race to develop antiviral medications
  • Rachel Lavin
  • October 10, 2021

HSE struggling to identify candidates for vaccine boosters

Tens of thousands of immunocompromised people need a third Covid vaccine dose, but the lack of a register makes identifying them difficult
  • Rachel Lavin
  • October 10, 2021

TCD’s Luke O’Neill says Electric Picnic should go ahead as test event

The immunology professor disagrees with Laois County Council’s decision to cancel the 70,000-attendee music festival, saying it could be held safely as a pilot event
  • Rachel Lavin
  • August 8, 2021

Luke O’Neill joins Open Orphan spin-off ahead of pharma firm’s IPO

Ambitions are high for Poolbeg Pharma, which will develop drugs to fight infectious diseases
  • Róisín Burke
  • June 20, 2021

How the Covid-19 vaccine plan could still deliver

Despite a rollercoaster week, the June target of vaccinating 3 million Irish adults is still within grasp.
  • Rachel Lavin
  • April 18, 2021

Government should begin delayed dosing programme this week, O‘Neill says

If the British 12-week delay strategy were applied to Ireland, it could result in 80 per cent of the adult population being vaccinated with a first dose by the end of May
  • Rachel Lavin
  • April 18, 2021

‘This could be huge’: how key figures realised the full extent of Covid-19

This time last year, most people had no idea of the coronavirus tidal wave that was about to hit us, but a handful of individuals realised the gravity of the situation straight away
  • Rachel Lavin
  • March 21, 2021

Willie O’Reilly: Luke is a tonic in the mutating virus narrative

As the finger-wagging and catastrophising increases, Professor Luke O’Neill gets the prize for clear, informative and uplifting communication
  • Willie O'Reilly
  • February 5, 2021

Business Post
Contact
Privacy Policy
Terms of Use
Data Access Request
Follow us
Download the app
Business Post Google App
Business Post iOS App
Part of the
Business Post Group